Wayland Signs Minimum 9,000 kilograms Supply Agreement with Cannamedical for Export of Product from Canada to Germany

Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) is pleased to announce that it has entered into an agreement to supply Cannamedical Pharma GmbH, a licensed, privately owned importer and distributor of cannabis in Germany to over 2,200 pharmacies with a minimum of 9,000 kilograms of EU-GMP certified cannabis flowers over a three year term.

Read more
Canopy Rivers Announces Significant Contract Manufacturing Agreement Between Portfolio Partners PharmHouse and TerrAscend

Canopy Rivers Inc. (TSXV:RIV) is pleased to announce PharmHouse Inc., has entered into an offtake agreement to supply TerrAscend Canada Inc., a wholly-owned subsidiary of TerrAscend Corp. (CSE:TER), with cannabis products from 20% of the flowering space at its 1.3 million square foot greenhouse facility until December 31, 2021.

Read more
Aurora Cannabis (NYSE | TSX: ACB) Increases Cornerstone Investment in Cannabis Retailer Choom (CSE: CHOO | OTC: CHOOF) with Additional $20 Million

Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and Choom Holdings Inc. (CSE: CHOO; OTCQB: CHOOF) an emerging adult use cannabis company that has secured one of the largest retail networks in Canada, are pleased to announce that the companies have completed a non-brokered private placement of a debenture in the principal amount of $20,000,000 in Choom by Aurora, convertible into common shares of Choom at a conversion price of $1.25 per Common Share, with a four year maturity date. Aurora has also secured the right to acquire up to 40% of the Company at $2.75 per Common Share.

Read more
Marijuana Powerhouse Surprise Move Reveals Rapidly Emerging Marijuana Hot Spot As Aurora Cannabis (TSX | NYSE: ACB) invests C$20 million into Choom Holdings (OTC:CHOOF | CSE:CHOO)

Dear Seed Investor,   The next stage of the marijuana boom starts now.   If you’re reading this, you’re going to get a head start on it all too.   Earlier today, Aurora Cannabis (TSX | NYSE: ACB) just announced it will invest C$20 million (about US$15 million) into Choom…

Read more
Canada gets the cannabis headlines, but the U.S. market is catching up

Canada has a challenger to its status as the pot-stock capital of the world — the scrappy over-the-counter market in the U.S.

The post Canada gets the cannabis headlines, but the U.S. market is catching up appeared first on The Cannifornian.

Read more
Voters favoring new marijuana rules in San Bernardino, Riverside counties

Voters approved ballot measures to allow and tax cannabis in every Inland Empire city where it was on the ballot Tuesday, Nov. 6, except one.

The post Voters favoring new marijuana rules in San Bernardino, Riverside counties appeared first on The Cannifornian.

Read more
Cannabis measure leads in Half Moon Bay

A controversial Half Moon Bay cannabis measure holds a narrow lead, suggesting that the town’s three greenhouse farmers will be allowed grow legal marijuana sprouts in “nurseries” – but residents have rejected other measures that would have expanded cultivation and sales in the traditional coastal town.

The post Cannabis measure leads in Half Moon Bay appeared first on The Cannifornian.

Read more
Kern County voters reject all cannabis measures

Two marijuana ballot measures were resoundingly rejected by Kern County voters on Tuesday, with another appearing to lose by a narrow margin.

The post Kern County voters reject all cannabis measures appeared first on The Cannifornian.

Read more
Session resignation prompts second cannabis-stock surge of the day

Cannabis stocks, already bolstered by wins in the midterm elections, got an added boost when anti-pot Attorney General Jeff Sessions announced his resignation Wednesday afternoon.

The post Session resignation prompts second cannabis-stock surge of the day appeared first on The Cannifornian.

Read more
InMed Pharmaceuticals (IMLFF) Reports First Quarter Fiscal 2019 Financial Results

marijuana stocks

InMed Pharmaceuticals Reports First Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update  InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary platform technologies to develop novel therapeutics for the treatment of diseases with high unmet medical needs, today reported financial results for the […]

The post InMed Pharmaceuticals (IMLFF) Reports First Quarter Fiscal 2019 Financial Results appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )